Lombardi, G., Del Bianco, P., Brandes, A., Eoli, M., Rudà, R., Ibrahim, T., . . . Zagonel, V. (2019). OS7.3 Health-related quality of life (HRQoL) evaluation in the REGOMA trial: A randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients. Neuro Oncol.
Stile di citazione ChicagoLombardi, G., et al. "OS7.3 Health-related Quality of Life (HRQoL) Evaluation in the REGOMA Trial: A Randomized, Phase II Clinical Trial Analyzing Regorafenib Activity in Relapsed Glioblastoma Patients." Neuro Oncol 2019.
Citazione MLALombardi, G., et al. "OS7.3 Health-related Quality of Life (HRQoL) Evaluation in the REGOMA Trial: A Randomized, Phase II Clinical Trial Analyzing Regorafenib Activity in Relapsed Glioblastoma Patients." Neuro Oncol 2019.